Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells…. Read the full story from the UCSD Newsroom
Thomas Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, is principal investigator of the study, which was reported in the Proceedings of the National Academy of Sciences.
Citation for the published study: Zhang S, Wu CCN, Fecteau J-F, Cui B, Chen L, Zhang L, Wu R, Rassenti L, Lao F, Weigand S, Kipps TJ. Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44 PNAS 2013; published ahead of print March 25, 2013, doi:10.1073/pnas.1221841110 | Read the abstract